Sodium–glucose cotransporter 2 inhibitor‐induced changes in body composition and simultaneous changes in metabolic profile: 52‐week prospective <scp>LIGHT</scp> (Luseogliflozin: the Components of Weight Loss in Japanese Patients with Type 2 Diabetes Mellitus) StudyTakashi Sasaki, Masahiro Fukuda, Masahiro Sugawara|Journal of Diabetes Investigation|2018Cited by 120